PERK recruits E-Syt1 at ER-mitochondria contacts for mitochondrial lipid transport and respiration.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
06 03 2023
Historique:
received: 02 06 2022
revised: 07 12 2022
accepted: 19 01 2023
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 3 3 2023
Statut: ppublish

Résumé

The integrity of ER-mitochondria appositions ensures transfer of ions and phospholipids (PLs) between these organelles and exerts crucial effects on mitochondrial bioenergetics. Malfunctions within the ER-mitochondria contacts altering lipid trafficking homeostasis manifest in diverse pathologies, but the molecular effectors governing this process remain ill-defined. Here, we report that PERK promotes lipid trafficking at the ER-mitochondria contact sites (EMCS) through a non-conventional, unfolded protein response-independent, mechanism. PERK operates as an adaptor for the recruitment of the ER-plasma membrane tether and lipid transfer protein (LTP) Extended-Synaptotagmin 1 (E-Syt1), within the EMCS. In resting cells, the heterotypic E-Syt1-PERK interaction endorses transfer of PLs between the ER and mitochondria. Weakening the E-Syt1-PERK interaction or removing the lipid transfer SMP-domain of E-Syt1, compromises mitochondrial respiration. Our findings unravel E-Syt1 as a PERK interacting LTP and molecular component of the lipid trafficking machinery of the EMCS, which critically maintains mitochondrial homeostasis and fitness.

Identifiants

pubmed: 36821088
pii: 213891
doi: 10.1083/jcb.202206008
pmc: PMC9998969
pii:
doi:

Substances chimiques

eIF-2 Kinase EC 2.7.11.1
EIF2AK3 protein, human EC 2.7.11.1
Phospholipids 0
Synaptotagmin I 0
SYT1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 Sassano et al.

Références

Dev Cell. 2019 Nov 18;51(4):476-487.e7
pubmed: 31743662
Cell Rep. 2013 Nov 14;5(3):813-25
pubmed: 24183667
Biochim Biophys Acta Mol Cell Res. 2017 Sep;1864(9):1439-1449
pubmed: 28554774
Cell Rep. 2018 Mar 13;22(11):2827-2836
pubmed: 29539413
Cell. 2013 Jun 20;153(7):1494-509
pubmed: 23791178
EMBO J. 2013 Aug 28;32(17):2348-61
pubmed: 23921556
Methods Mol Biol. 2021;2295:29-41
pubmed: 34047970
Biochim Biophys Acta. 2013 Nov;1833(11):2526-41
pubmed: 23380708
Biol Rev Camb Philos Soc. 2022 Oct;97(5):1737-1748
pubmed: 35475315
J Cell Biol. 2006 Sep 25;174(7):915-21
pubmed: 16982799
Nat Commun. 2019 Mar 20;10(1):1287
pubmed: 30894536
Nat Commun. 2018 Jun 27;9(1):2500
pubmed: 29950559
FEBS J. 2019 Jan;286(2):241-278
pubmed: 30027602
Cell Metab. 2021 Mar 2;33(3):598-614.e7
pubmed: 33592173
Cell. 2019 May 2;177(4):881-895.e17
pubmed: 31051106
Mol Biol Cell. 2016 Jul 15;27(14):2161-71
pubmed: 27226479
Proc Natl Acad Sci U S A. 1984 May;81(9):2669-73
pubmed: 6425837
J Biol Chem. 1991 May 5;266(13):7978-81
pubmed: 2022626
Cell Calcium. 2021 Sep;98:102453
pubmed: 34399235
J Biol Chem. 1990 May 5;265(13):7248-56
pubmed: 2332429
EMBO J. 2018 Jan 17;37(2):219-234
pubmed: 29222176
J Biol Chem. 1991 Jan 5;266(1):89-97
pubmed: 1898727
Cell. 2010 May 14;141(4):656-67
pubmed: 20478256
Structure. 2020 Jul 7;28(7):799-809.e5
pubmed: 32402247
Cell Rep. 2018 Oct 9;25(2):501-512.e3
pubmed: 30304688
Sci Rep. 2019 Mar 8;9(1):3975
pubmed: 30850711
Int J Mol Sci. 2021 Dec 28;23(1):
pubmed: 35008750
Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102
pubmed: 22251901
Biol Direct. 2020 Nov 11;15(1):24
pubmed: 33176847
Life Sci Alliance. 2020 Feb 6;3(3):
pubmed: 32029570
Nature. 1992 Jul 23;358(6384):325-7
pubmed: 1322496
J Biol Chem. 2012 May 4;287(19):15205-18
pubmed: 22403410
Mol Cell. 2019 Jun 6;74(5):877-890.e6
pubmed: 31023583
Cell Metab. 2013 Dec 3;18(6):908-19
pubmed: 24315374
Mol Cell. 2010 Jul 9;39(1):121-32
pubmed: 20603080
Nat Protoc. 2007;2(10):2480-91
pubmed: 17947990
Orphanet J Rare Dis. 2010 Nov 04;5:29
pubmed: 21050479
Nat Cell Biol. 2016 May;18(5):504-15
pubmed: 27065097
Methods Enzymol. 2000;327:440-56
pubmed: 11045002
Science. 1998 Jun 12;280(5370):1763-6
pubmed: 9624056
Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):650-662
pubmed: 30668969
FEBS Lett. 2018 Apr;592(8):1273-1290
pubmed: 29067684
Cancer Res. 2022 May 16;82(10):1969-1990
pubmed: 35404405
Science. 2017 Nov 3;358(6363):623-630
pubmed: 29097544
Front Oncol. 2017 Aug 18;7:174
pubmed: 28868254
Nat Genet. 2000 Aug;25(4):406-9
pubmed: 10932183
Cell Death Differ. 2021 Jun;28(6):1804-1821
pubmed: 33335290
Mol Cell Biol. 2017 May 2;37(10):
pubmed: 28242652
J Lipid Res. 2017 Mar;58(3):553-562
pubmed: 28119445
EMBO Rep. 2016 Jun;17(6):800-10
pubmed: 27113756
Science. 2009 Jul 24;325(5939):477-81
pubmed: 19556461
J Biol Chem. 2012 May 18;287(21):17589-17597
pubmed: 22433850
EMBO J. 2015 Sep 2;34(17):2291-305
pubmed: 26202220
J Bioenerg Biomembr. 2016 Apr;48(2):99-112
pubmed: 25627476
Mol Cell. 2017 Mar 2;65(5):885-899.e6
pubmed: 28238652
J Cell Sci. 2012 Oct 15;125(Pt 20):4791-9
pubmed: 22797914
IEEE Trans Image Process. 2013 Jan;22(1):119-33
pubmed: 22868570
J Biol Chem. 2013 Feb 8;288(6):4158-73
pubmed: 23250747
Biochim Biophys Acta Mol Cell Res. 2017 Sep;1864(9):1490-1493
pubmed: 28363589
Nat Immunol. 2022 Mar;23(3):431-445
pubmed: 35228694
Biochim Biophys Acta. 2014 Apr 4;1841(4):595-609
pubmed: 24316057
Nat Methods. 2019 Jan;16(1):67-70
pubmed: 30559429
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
pubmed: 17565364
Nat Rev Mol Cell Biol. 2020 Jan;21(1):7-24
pubmed: 31732717
Trends Endocrinol Metab. 2014 Oct;25(10):528-37
pubmed: 25048297
Curr Top Microbiol Immunol. 2018;414:73-102
pubmed: 28349285
Cells. 2019 Sep 12;8(9):
pubmed: 31547228
Cell Death Differ. 2012 Nov;19(11):1880-91
pubmed: 22705852
Mol Cell. 2000 May;5(5):897-904
pubmed: 10882126
PLoS Biol. 2014 Oct 14;12(10):e1001969
pubmed: 25313861

Auteurs

Maria Livia Sassano (ML)

Cell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.
VIB Center for Cancer Biology , Leuven, Belgium.

Alexander R van Vliet (AR)

Cell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.

Ellen Vervoort (E)

Cell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.
VIB Center for Cancer Biology , Leuven, Belgium.

Sofie Van Eygen (S)

Cell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.
VIB Center for Cancer Biology , Leuven, Belgium.

Chris Van den Haute (C)

Research Group for Neurobiology and Gene Therapy, Department of Neuroscience, Leuven Viral Vector Core, KU Leuven , Leuven, Belgium.

Benjamin Pavie (B)

VIB-bioimaging Center UGent , Ghent, Belgium.

Joris Roels (J)

VIB-bioimaging Center UGent , Ghent, Belgium.
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay , Gif-sur-Yvette, France.

Johannes V Swinnen (JV)

Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven , Leuven, Belgium.

Marco Spinazzi (M)

Neuromuscular Reference Center, CHU Angers , Angers, France.

Leen Moens (L)

Laboratory for Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, Department of Pediatrics, University Hospitals Leuven , Leuven, Belgium.

Kristina Casteels (K)

Woman and Child, Department for Development and Regeneration, KU Leuven, Department of Pediatrics, University Hospitals Leuven , Leuven, Belgium.

Isabelle Meyts (I)

Laboratory for Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, Department of Pediatrics, University Hospitals Leuven , Leuven, Belgium.

Paolo Pinton (P)

Department of Medical Sciences, University of Ferrara , Ferrara, Italy.

Saverio Marchi (S)

Department of Clinical and Molecular Sciences, Marche Polytechnic University , Ancona, Italy.

Leila Rochin (L)

Inserm , Gif-sur-Yvette, France.

Francesca Giordano (F)

Inserm , Gif-sur-Yvette, France.

Blanca Felipe-Abrio (B)

Cell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.
VIB Center for Cancer Biology , Leuven, Belgium.

Patrizia Agostinis (P)

Cell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.
VIB Center for Cancer Biology , Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH